Characteristics | Total (n=1799) | STEMI/new LBBB (n=463) | UA/NSTEMI (n=1336) | p Value |
---|---|---|---|---|
Medications, n (%) | ||||
Aspirin | 1773 (98.6) | 460 (99.4) | 1313 (98.3) | 0.095 |
Clopidogrel | 1652 (91.8) | 454 (98.1) | 1198 (89.7) | <0.0001 |
Other antiplatelets | 15 (0.8) | 6 (1.3) | 9 (0.7) | 0.235 |
Dual antiplatelet therapy | 1640 (91.2) | 452 (97.6) | 1188 (88.9) | <0.0001 |
UFH | 864 (48.0) | 230 (49.7) | 634 (47.5) | 0.410 |
LMWH | 817 (45.4) | 197 (42.5) | 620 (46.4) | 0.151 |
Statin | 1697 (94.3) | 441 (95.2) | 1256 (94.0) | 0.322 |
β-blocker | 1606 (89.3) | 421 (90.9) | 1185 (88.7) | 0.181 |
ACEI/ARB | 1473 (81.9) | 403 (87.0) | 1070 (80.1) | 0.001 |
Nitrates | 1653 (91.9) | 417 (90.1) | 1236 (92.5) | 0.096 |
Oral antiglycaemic agents | 228 (12.7) | 36 (7.8) | 192 (14.4) | <0.0001 |
PPIs | 746 (41.5) | 206 (44.5) | 540 (40.4) | 0.125 |
ACEI, ACE inhibitor; ARB, angiotensin receptor blocker; LBBB, left bundle branch block; LMWH, low-molecular-weight heparin; NSTEMI, non-ST-segment elevation myocardial infarction; PPIs, proton-pump inhibitors; STEMI, ST-segment elevation myocardial infarction; UA, unstable angina; UFH, unfractionated heparin.